T-h-2 immunity and CD3+ CD45RBlow-activated T cells in mice immunized with recombinant bacillus Calmette-Guérin expressing HIV-1 principal neutralizing determinant epitope

FEMS Immunology and Medical Microbiology

Volumn 47, Issue 1, 2006, Pages 45-55

  Aravindhan, Vivekanandhan ^a   Narayanan, Sujatha ^a   Gautham, Namasivayam ^b   Prasad, Vinayaka ^c   Kannan, P ^a   Jacobs Jr , William R ^c   Narayanan, Paranji R ^a  

^a NATIONAL INSTITUTE FOR RESEARCH IN TUBERCULOSIS   (India)

^b UNIVERSITY OF MADRAS   (India)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Chaperonin 10 (Cpn10) promoter; Cryptic epitopes; Epitope trap vector; HIV 1 principal neutralizing determinant (PND); Recombinant bacillus Calmette Gu rin (r BCG)

Indexed keywords

BCG VACCINE; CD3 ANTIGEN; CD45RB ANTIGEN; CHAPERONIN; CHIMERIC ANTIBODY; EPITOPE; GAMMA INTERFERON; HEAT SHOCK PROTEIN 65; IMMUNOGLOBULIN G ANTIBODY; INTERLEUKIN 4; PRINCIPAL NEUTRALIZING DETERMINANT; PRINCIPAL NEUTRALIZING DETERMINANT IMMUNOGLOBULIN G ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY TITER; ANTIGEN EXPRESSION; ARTICLE; BCG VACCINATION; CELL POLARITY; CELL SPECIFICITY; CELLULAR IMMUNITY; CHIMERA; CONTROLLED STUDY; CYTOKINE PRODUCTION; EPITOPE MAPPING; FEMALE; GENETIC ENGINEERING; HUMAN IMMUNODEFICIENCY VIRUS 1; LYMPHOCYTE PROLIFERATION; MOUSE; MYCOBACTERIUM BOVIS; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; SPLEEN CELL; T LYMPHOCYTE ACTIVATION; TH2 CELL;

ANIMALS; ANTIBODY FORMATION; ANTIGENS, CD3; ANTIGENS, CD45; BASE SEQUENCE; BCG VACCINE; CHAPERONIN 10; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HIV-1; HYPERSENSITIVITY, DELAYED; IMMUNIZATION; IMMUNODOMINANT EPITOPES; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; MYCOBACTERIUM TUBERCULOSIS; T-LYMPHOCYTES; TH2 CELLS;

EID: 33646718148     PISSN: 09288244     EISSN: 1574695X     Source Type: Journal    
DOI: 10.1111/j.1574-695X.2006.00061.x     Document Type: Article

References (34)

1. Agnello D Scanziani E Di GM Leoni F Modena D Mascagni P Introna M Ghezzi P Villa P 2002 Preventive administration of Mycobacterium tuberculosis 10-kDa heat shock protein (hsp10) suppresses adjuvant arthritis in Lewis rats. Int Immunopharmacol 2: 463 474.
2. Aldovini A Young RA 1991 Humoral and cell-mediated immune responses to live recombinant BCG-HIV vaccines. Nature 351: 479 482.
3. Andersson GE Sharp PM 1996 Codon usage in the Mycobacterium tuberculosis complex. Microbiology 142: 915 925.
4. Aronson NE Santosham M Comstock GW Howard RS Moulton LH Rhoades ER Harrison LH 2004 Long-term efficacy of BCG vaccine in American Indians and Alaska Natives: a 60-year follow-up study. J Am Med Assoc 291: 2086 2091.
5. Baird PN Hall LM Coates AR 1989 Cloning and sequence analysis of the 10 kDa antigen gene of Mycobacterium tuberculosis. J Gen Microbiol 135: 931 939.
6. Barnes PF Mehra V Rivoire B Fong SJ Brennan PJ Voegtline MS Minden P Houghten RA Bloom BR Modlin RL 1992 Immunoreactivity of a 10-kDa antigen of Mycobacterium tuberculosis. J Immunol 148: 1835 1840.
7. Ben-Nun A Mendel I Sappler G Kerlero de Rosbo NA 1995 12-kDa protein of Mycobacterium tuberculosis protects mice against experimental autoimmune encephalomyelitis Protection in the absence of shared T cell epitopes with encephalitogenic proteins.. J Immunol 154: 2939 2948.
8. Chen L Wang J Zganiacz A Xing Z 2004 Single intranasal mucosal Mycobacterium bovis BCG vaccination confers improved protection compared to subcutaneous vaccination against pulmonary tuberculosis. Infect Immun 72: 238 246.
9. Cheng CW Ng MT Chan SY Sun WH 2004 Low dose BCG as adjuvant therapy for superficial bladder cancer and literature review. Aust N Z J Surg 74: 569 572.
10. Croft M Bradley LM Swain SL 1994 Naive versus memory CD4 T cell response to antigen. Memory cells are less dependent on accessory cell costimulation and can respond to many antigen-presenting cell types including resting B cells. J Immunol 152: 2675 2685.
11. da Cruz FW McBride AJ Conceicao FR Dale JW McFadden J Dellagostin OA 2001 Expression of the B-cell and T-cell epitopes of the rabies virus nucleoprotein in Mycobacterium bovis BCG and induction of an humoral response in mice. Vaccine 20: 731 736.
12. Dennehy M Williamson AL 2005 Factors influencing the immune response to foreign antigen expressed in recombinant BCG vaccines. Vaccine 23: 1209 1224.
13. Fomsgaard A Nielsen HV Bryder K Nielsen C Machuca R Bruun L Hansen J Buus S 1998 Improved humoral and cellular immune responses against the gp120 V3 loop of HIV-1 following genetic immunization with a chimeric DNA vaccine encoding the V3 inserted into the hepatitis B surface antigen. Scand J Immunol 47: 289 295.
14. Hetzel C Janssen R Ely SJ Kristensen NM Bunting K Cooper JB Lamb JR Young DB Thole JE 1998 An epitope delivery system for use with recombinant mycobacteria. Infect Immun 66: 3643 3648.
15. Ikemura T 1981 Correlation between the abundance of Escherichia coli transfer RNAs and the occurrence of the respective codons in its protein genes. J Mol Biol 146: 1 21.
16. Matsuo K Yamaguchi R Yamazaki A Tasaka H Terasaka K Totsuka M Kobayashi K Yukitake H Yamada T 1990 Establishment of a foreign antigen secretion system in mycobacteria. Infect Immun 58: 4049 4054.
17. McKenzie AN 2000 Regulation of T helper type 2 cell immunity by interleukin-4 and interleukin-13. Pharmacol Ther 88: 143 151.
18. Mehra V Bloom BR Bajardi AC, et al 1992 A major T cell antigen of Mycobacterium leprae is a 10-kD heat-shock cognate protein. J Exp Med 175: 275 284.
19. Minden P Kelleher PJ Freed JH Nielsen LD Brennan PJ McPheron L McClatchy JK 1984 Immunological evaluation of a component isolated from Mycobacterium bovis BCG with a monoclonal antibody to M. bovis BCG. Infect Immun 46: 519 525.
20. Murray PJ Aldovini A Young RA 1996 Manipulation and potentiation of antimycobacterial immunity using recombinant bacillus Calmette-Guerin strains that secrete cytokines. Proc Natl Acad Sci USA 93: 934 939.
21. Paul WE 1991 Interleukin-4: a prototypic immunoregulatory lymphokine. Blood 77: 1859 1870.
22. Del Prete G Romagnani S 1994 The role of TH1 and TH2 subsets in human infectious diseases. Trends Microbiol 2: 4 6.
23. Rao V Dhar N Shakila H, et al 2005 Increased expression of Mycobacterium tuberculosis 19 kDa lipoprotein obliterates the protective efficacy of BCG by polarizing host immune responses to the Th2 subtype. Scand J Immunol 61: 410 417.
24. Reese MG 2001 Application of a time-delay neural network to promoter annotation in the Drosophila melanogaster genome. Comput Chem 26: 51 56.
25. Rizzuto CD Wyatt R Hernandez-Ramos N Sun Y Kwong PD Hendrickson WA Sodroski J 1998 A conserved HIV gp120 glycoprotein structure involved in chemokine receptor binding. Science 280: 1949 1953.
26. Robinson HL Amara RR 2005 T cell vaccines for microbial infections. Nat Med 11: S25 S32.
27. Romagnani S 1996 Th1 and Th2 in human diseases. Clin Immunol Immunopathol 80: 225 235.
28. Stanford MM McFadden G 2005 The 'supervirus'? Lessons from IL-4-expressing poxviruses. Trends Immunol 26: 339 345.
29. Stewart GR Wernisch L Stabler R Mangan JA Hinds J Laing KG Young DB Butcher PD 2002 Dissection of the heat-shock response in Mycobacterium tuberculosis using mutants and microarrays. Microbiology 148: 3129 3138.
30. Stover CK de la Cruz VF Fuerst TR, et al 1991 New use of BCG for recombinant vaccines. Nature 351: 456 460.
31. Taneja B Mande SC 2002 Structure of Mycobacterium tuberculosis chaperonin-10 at 3.5 A resolution. Acta Crystallogr D: Biol Crystallogr 58: 260 266.
32. Wards BJ Collins DM 1996 Electroporation at elevated temperatures substantially improves transformation efficiency of slow-growing mycobacteria. FEMS Microbiol Lett 145: 101 105.
33. Watkins AD Hatfield CA Fidler SF, et al 1996 Phenotypic analysis of airway eosinophils and lymphocytes in a Th-2-driven murine model of pulmonary inflammation. Am J Respir Cell Mol Biol 15: 20 34.
34. Wells JA Vasser M Powers DB 1985 Cassette mutagenesis: an efficient method for generation of multiple mutations at defined sites. Gene 34: 315 323.